Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations.

@article{Judkins2005ApplicationOE,
  title={Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations.},
  author={Thaddeus Judkins and Brant C Hendrickson and Amie M. Deffenbaugh and Kristilyn Eliason and Beno{\^i}t Leclair and M. Jay Norton and Brian E. Ward and Dmitri Pruss and Thomas A Scholl},
  journal={Cancer research},
  year={2005},
  volume={65 21},
  pages={10096-103}
}
This work describes an approach to characterize the clinical significance of genetic variants detected during the genetic testing of BRCA1 in patients from hereditary breast/ovarian cancer families. Results from transgenic mice and extensive clinical testing support the hypothesis that biallelic BRCA1 mutations result in embryonic lethality. Therefore, it is reasonable to conclude that variants of uncertain clinical significance found to reside in trans with known deleterious mutations impart… CONTINUE READING